David M. Epstein's Net Worth
$6.02 Million
Who is David M. Epstein?
David M. Epstein has an estimated net worth of $6.02 Million. This is based on reported shares across multiple companies, which include MetaStat, Inc., Black Diamond Therapeutics, Inc., OSI PHARMACEUTICALS INC, and GYRE THERAPEUTICS, INC..
SEC CIK
David M. Epstein's CIK is 0001488668
Past Insider Trading and Trends
2020 was David M. Epstein's most active year for acquiring shares with 7 total transactions. David M. Epstein's most active month to acquire stocks was the month of January. 2020 was David M. Epstein's most active year for disposing of shares, totalling 11 transactions. David M. Epstein's most active month to dispose stocks was the month of May. 2020 saw David M. Epstein paying a total of $73,830.00 for 537,290 shares, this is the most they've acquired in one year. In 2010 David M. Epstein cashed out on 76,588 shares for a total of $4,404,870.02, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MetaStat, Inc. No price found
InvestorDavid M. Epstein owns 217,435 units of Common Stock.acquired a total of 117,435 shares in MetaStat, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +110.50% | 332.21K |
$1.10 | $250,000.30 | 632.84K |
Jun 30 - Oct 14
| |||
Form 4
| +12.50% | 12.5K |
—
|
—
| 112.5K |
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Black Diamond Therapeutics, Inc. (BDTX) Snapshot price: $5.4
SEE REMARKSDavid M. Epstein owns 671,423 units of Common Stock which is worth $3,625,684.20. In the year 2020 David M. Epstein filed a total of 12 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.59% | -25.00K |
$6.70 | -$167,500.00 | 671.42K |
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
| -1.28% | -9.00K |
$18.77 | -$354,244.94 | 696.42K |
Scheduled
|
Jan 4
| ||
Form 4
| +0.36% | 2.5K |
$6.42 | $16,050.00 | 705.42K |
Dec 15
| |||
Form 4
| -1.26% | -9.00K |
$19.57 | -$373,313.74 | 702.92K |
Scheduled
|
Dec 1
| ||
Form 4
| -1.25% | -9.00K |
$18.78 | -$354,396.39 | 711.92K |
Scheduled
|
Nov 2
| ||
Form 4
| -1.23% | -9.00K |
$18.38 | -$344,702.40 | 720.92K |
Scheduled
|
Oct 1
| ||
Form 4
| +56.01% | 270.35K |
—
|
—
| 753.01K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OSI PHARMACEUTICALS INC No price found
Sr. VP and CSO, OncologyDavid M. Epstein used to own units in Common Stock but no longer holds any shares there. In the year 2010 David M. Epstein filed a total of 4 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -8.00 |
$57.50 | -$460.00 |
0
|
Jun 7
| |||
Form 4
| -99.94% | -13.34K |
$57.50 | -$767,050.00 | 8 |
Jun 3
| |||
Form 4
| -6.36% | -906.00 |
$58.67 | -$53,155.02 | 13.34K |
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GYRE THERAPEUTICS, INC. (GYRE) Snapshot price: $13.77
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||